Adage Capital Management, L.P. has significantly increased its stake in Equillium, Inc., according to an amended Schedule 13G filed with the SEC. This filing reveals that Adage now holds 5.93% of Equillium's common stock, which amounts to approximately 3,966,917 shares. This update is crucial for Equillium as it reflects an important shift in ownership that could impact the company's strategic direction and investor relations.

Background

Equillium, Inc. is a Delaware-based company that operates in the pharmaceutical preparations sector, specifically under the SIC code 2834. The company is publicly traded on the Nasdaq under the ticker symbol EQ. Recent filings include a Schedule 13G/A on November 12, 2026, a Form S-3, and a Form 10-Q, all filed on the same day. These filings indicate ongoing activity and potential developments within the company.

What the Filing Says

The amended Schedule 13G/A indicates that Adage Capital Management holds a total of 3,966,917 shares of Equillium, which includes 3,442,514 shares that are issuable upon the exercise of warrants. The filing states, "Includes 3,442,514 shares of Common Stock issuable upon exercise of warrants." This significant stake positions Adage as a notable influencer in Equillium's future decisions.

Impact

This increase in ownership could affect various stakeholders, including existing shareholders, potential investors, and the management team at Equillium. The presence of a substantial investment firm like Adage Capital Management may lead to increased scrutiny of the company's operations and strategic decisions, as well as potential changes in governance or strategic direction.

What's Next

The filing does not say what happens next. However, given the size of Adage's stake, it is likely that further disclosures or actions may follow as the company navigates its relationship with this significant shareholder.